SCHEDULE 13G: Intracoastal Capital and Affiliates Disclose Increased Passive Stake in Microbot Medical Inc. to 8.8%

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a passive beneficial ownership of 8.8% in Microbot Medical Inc. as of January 10, 2025.

Summary

• The Schedule 13G filing identifies Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC as the Reporting Persons.
• As of January 10, 2025, the Reporting Persons collectively beneficially own 2,672,084 shares of Microbot Medical Inc. common stock.
• This ownership represents approximately 8.8% of Microbot Medical Inc.'s common stock.
• The beneficial ownership includes 322,596 shares directly held by Intracoastal Capital LLC and 2,349,488 shares issuable upon exercise of Intracoastal Warrant 4.
• The 8.8% ownership calculation is based on 20,242,119 shares outstanding as of January 3, 2025, plus 4,000,001 shares issued from one Securities Purchase Agreement (SPA), 3,788,550 shares from a second SPA, and the 2,349,488 shares from Intracoastal Warrant 4.
• Several other warrants (Intracoastal Warrant 1, 2, and 3) are excluded from the beneficial ownership calculation due to 'blocker provisions' that prevent exercise if it would result in ownership exceeding 4.99%.
• Without these blocker provisions, the Reporting Persons' potential beneficial ownership would be 6,191,768 shares.
• The filing is a Schedule 13G, indicating a passive investment purpose, with the Reporting Persons certifying that the securities were not acquired to change or influence control of the issuer.

Sentiment

Score: 6

Explanation: The document is a factual disclosure of increased passive ownership, which is generally a neutral to slightly positive signal for a company as it indicates investor confidence. The increase in stake from 5.8% to 8.8% in a short period suggests continued investment.

Positives

• The increased institutional ownership by a group of investors, growing from 5.8% on January 6, 2025, to 8.8% by January 10, 2025, may signal growing investor confidence in Microbot Medical Inc.'s long-term prospects.
• The passive nature of the investment, as indicated by the Schedule 13G filing, suggests a long-term holding strategy rather than an activist intent.

Risks

• The document does not explicitly detail risks for Microbot Medical Inc. related to its operations or financial health. It is a disclosure of ownership.

Future Outlook

The document is a disclosure of current beneficial ownership and does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction. It indicates the Reporting Persons' passive investment intent.

Management Comments

• The Reporting Persons certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing indicates a significant increase in a passive institutional stake in Microbot Medical Inc., a company likely operating in the medical device or biotechnology sector given its name. Such an increase in ownership by a group of investors can be viewed positively by the market, suggesting a vote of confidence in the company's long-term prospects or valuation, aligning with broader trends of institutional interest in specific growth sectors.

Comparison to Industry Standards

• As a Schedule 13G filing, this document primarily reports beneficial ownership and does not contain financial or operational results that can be directly compared to industry standards or specific comparable companies/projects.
• The ownership percentage of 8.8% by a single group is substantial and indicates a significant passive stake, which is common for institutional investors taking positions in smaller-cap companies within the medical technology sector.

Stakeholder Impact

• Shareholders: The increased stake by a group of investors could be perceived as a positive signal, potentially increasing investor confidence and demand for the stock. The issuance of new shares through the SPAs would result in dilution for existing shareholders.

Next Steps

• The document does not specify future actions or milestones for Microbot Medical Inc. or the Reporting Persons, beyond the ongoing passive investment.

Key Dates

Keywords

Microbot Medical Inc., Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Passive Investment, Warrants, Equity Stake